Emergent BioSolutions

Emergent BioSolutions to acquire Adapt Pharma for up to $735m

Emergent BioSolutions has agreed to acquire Ireland-based Adapt Pharma for an upfront payment of $635m, followed by up to $100m…

Emergent BioSolutions to acquire PaxVax for $270m

US-based life sciences company Emergent BioSolutions has signed an agreement to purchase specialty vaccines developer PaxVax for $270m under a…